Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below.
Rep. Nancy Pelosi (D-CA) stands to make a massive profit on an options trade she made on an AI stock. The Nancy Pelosi tracker on X cited Pelosi’s SEC disclosures, which show she bought 50 call options of Tempus AI (NASDAQ TEM) stock options at a strike price of $20. Tempus AI’s stock surged by 183% after Pelosi’s disclosure became public. Keep reading to discover why Pelosi likes Tempus AI so much.
The surge in Tempus stock is indicative of how many investors monitor and mimic Pelosi’s trading activity. They do that for one simple reason: she has an uncanny knack for making profitable trades. Cryptopolitan quotes information from the Unusual Whales website showing Pelosi investments generated an impressive 70.9% return in 2024. The S&P 500’s 24.9% return looks paltry by comparison.
Don’t Miss:
In fairness to Tempus AI, Pelosi can’t take all the credit for their stock being hot. The AI sector is booming and Tempus has a proprietary AI analytics program, Lens. More importantly, Tempus AI just announced a partnership with the Institute for Follicular Lymphoma Innovation, which will use Lens to help develop cures for follicular lymphoma. Cryptopolitan reported that the global market for follicular lymphoma cures is expected to be worth $4.65 billion by 2030.
Tempus AI also just released its Q4 2024 earnings and the highlights include:
-
Annual revenue of $693.4 million—a 30% year-on-year increase
-
$381.1 million increase in annual gross profit—33.2% year-on-year increase
-
$104.7 million in adjusted EBITDA–$49.5 million year-on-year increase
Trending: If there was a new fund backed by Jeff Bezos offering a 7-9% target yield with monthly dividends would you invest in it?
The earnings release included a statement from CEO Eric Lefkofsky. “Our performance in 2024 reflects the strength of our core businesses, as Genomics continued to show strong volume growth, and our Data business delivered record results throughout the year,” he said. Despite Lefkofsky’s rosy outlook, Tempus AI shares fell sharply on cost concerns and are currently trading at $59.10.
